Trial · NCT04185220
Results by group103
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 103
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximum Tolerated Dose (MTD) of Recombinant Human Interleukin 15 (IL-15) (rhIL-15) | All Participants | 2 | mcg/kg/day | ||
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Alanine aminotransferase increased | 2 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Alanine aminotransferase increased | 1 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Aspartate aminotransferase increased | 2 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Aspartate aminotransferase increased | 1 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Bronchial infection | 1 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Bronchial infection | 0 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Chills | 1 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Chills | 0 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Diarrhea | 1 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Diarrhea | 0 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Dysgeusia | 2 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Dysgeusia | 0 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Fatigue | 2 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Fatigue | 0 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Fever | 9 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Fever | 1 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Hypomagnesemia | 5 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 2 (Interleukin-15 4mcg/kg/Day) | Grade 1 Hypomagnesemia | 0 | adverse events | |
| Number of Grade 1-4 Treatment Related Adverse Events | Dose Level 1 (Interleukin-15 2mcg/kg/Day) | Grade 1 Neutrophil count decreased | 1 | adverse events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04185220/results